Abomics

📍 Turku, Finland🗓 Founded 2013👥 20 employees💰 Last funded May 2026
Abomics is a Finnish health technology company founded in 2013 by medical doctors that specializes in pharmacogenetics. We support healthcare professionals with pharmacogenetic solutions that enable precision medication. Pharmacogenetic testing helps identify more effective and safer medication and dosages, reducing trial-and-error prescribing and minimizing the risk of adverse drug reactions. Our solutions are designed to integrate seamlessly into clinical workflows bringing pharmacogenetic insights into everyday clinical decision-making. Built on scientific evidence and clinical expertise, we are a trusted partner to hospitals, laboratories, pharmaceutical companies, genomic service providers, and biobanks. Our PGx solutions: • Interpretation • Medical guidance • System integration • Medical databases • Consultation and education We work closely with each customer to deliver customisable solution that meets your needs in pharmacogenetics. Let’s take a next step in PGx together. 📩 Contact us: info@abomicspgx.com 🔗 Learn more: abomicspgx.com 📍 Based in Finland. Supporting healthcare providers globally. ✅ ISO 13485:2016 certified, ensuring safe, compliant, and high-quality pharmacogenetic services
3
Total investors
2
Early stage
0
Mid stage
0
Late stage
2013
Founded
Investor geography1 country
Finland
2
Investor activity2012–2026 · investors recorded per year
201212015120261
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Abomics?
Abomics has 3 investors on record on gritt.io, including 2 early-stage backers.
When did Abomics last raise funding?
The most recent investment in Abomics recorded on gritt.io was in May 2026.
When was Abomics founded?
Abomics was founded in 2013.
What industry is Abomics in?
Abomics operates in Hospitals and Health Care. Find similar Hospitals and Health Care investors on gritt.io.
Where is Abomics based?
Abomics is headquartered in Turku, Finland.